FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Inventia Healthcare Chlorthalidone Tablets Recall

Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactu…

Inventia Healthcare Limited

Risk level
Class II
Reported by FDA
Jun 24, 2026
Recall ID
D-0610-2026
Check your lot numberHow we source this data

Summary

Inventia Healthcare recalled Chlorthalidone Tablets starting Jun 5, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0610-2026 on Jun 24, 2026. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Lot numbers, UPCs & expiration codes

[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027

Where it was sold

U.S. Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0610-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 5, 2026
FDA report date
Jun 24, 2026
Quantity
11,460 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Inventia Healthcare Limited

Original FDA data

Every field from FDA enforcement report D-0610-2026, exactly as published.

Show all FDA fields
City
Kalyan
Status
Ongoing
Country
India
Event ID
99136
Address
Additional Ambernath Midc
Address (line 2)
Ambernath East; F1-F1/1-F75/1
Code information
[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027
Report date
Jun 24, 2026
Product type
Drugs
Recall number
D-0610-2026
Classification
Class II
Recalling firm
Inventia Healthcare Limited
Product quantity
11,460 bottles
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Distribution pattern
U.S. Nationwide.
Recall initiation date
Jun 5, 2026
Initial firm notification
Letter
Center classification date
Jun 22, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0610-2026, published Jun 24, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls